Cargando…

Rapidly starting antiretroviral therapy to improve outcomes among disadvantaged groups

Detalles Bibliográficos
Autores principales:	Ford, Nathan, Crawford, Keith W., Ameyan, Wole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Editorial Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505146/ https://www.ncbi.nlm.nih.gov/pubmed/34602591 http://dx.doi.org/10.1097/QAD.0000000000003052

Ejemplares similares

Shifting the narrative: from “the missing men” to “we are missing the men”
por: Grimsrud, Anna, et al.
Publicado: (2020)

Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?
por: Franco-Paredes, Carlos, et al.
Publicado: (2017)

The last pre-pandemic European Renal Association Registry report: age at start of kidney replacement therapy in Europe
por: Carriazo, Sol, et al.
Publicado: (2021)

Future directions for HIV service delivery research: Research gaps identified through WHO guideline development
por: Ford, Nathan, et al.
Publicado: (2021)

Are clinical outcomes from COVID-19 improving in ethnic minority groups?
por: Pan, Daniel, et al.
Publicado: (2023)

When to start antiretroviral therapy in resource-limited settings: a human rights analysis
por: Ford, Nathan, et al.
Publicado: (2010)

Editorial Commentary: Immunodeficiency at Start of Antiretroviral Therapy: The Persistent Problem of Late Presentation to Care
por: Ford, Nathan, et al.
Publicado: (2015)

When to start clean intermittent catheterization (CIC) in children with neurogenic bladder dysfunction
por: Rondon, Atila
Publicado: (2021)

Rapid start antiretroviral therapies for improved engagement in HIV care: implementation science evaluation protocol
por: Bourdeau, Beth, et al.
Publicado: (2023)

Universal coronavirus vaccines: the time to start is now
por: Giurgea, Luca T., et al.
Publicado: (2020)

The starting line for COVID-19 vaccine development
por: Lee, Nelson, et al.
Publicado: (2020)

When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010)

COVID-19 vaccination advice via SMS-based video to improve vaccination uncertainty in at-risk groups
por: Bateman, James, et al.
Publicado: (2021)

Tailored Antiplatelet Therapy in Patients Undergoing PCI: Is Rapid Bedside Genetic Testing the Answer?
por: Faxon, David P.
Publicado: (2020)

Modulating Mesothelin Shedding to Improve Therapy
por: Zhang, Yujian, et al.
Publicado: (2012)

Two-Dimensional Speckle-Tracking Echocardiography in Normal Korean Population: Is Now to Start Using in Routine Clinical Practice?
por: Na, Jin Oh
Publicado: (2016)

Pediatric cardiac care for the economically disadvantaged in India: Problems and prospects
por: Kothari, Shyam S
Publicado: (2009)

The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)

When to start vasopressin in septic shock: the strategy we propose
por: Guerci, Philippe, et al.
Publicado: (2022)

Evidence for a personalized early start of norepinephrine in septic shock
por: Monnet, Xavier, et al.
Publicado: (2023)

A bad start for socioeconomically disadvantaged children.
por: Olden, K
Publicado: (1996)

Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes
por: Vogel, Joshua P, et al.
Publicado: (2022)

Disadvantages (?) of Menthol
Publicado: (1911)

Benefits and risks of rapid initiation of antiretroviral therapy
por: Ford, Nathan, et al.
Publicado: (2018)

Coordinating efforts to optimize next-generation kidney replacement therapies: the European Kidney Health Alliance Work Group ‘Breakthrough Innovation’
por: Wieringa, Fokko, et al.
Publicado: (2023)

Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission
Publicado: (2021)

The science of rapid start—From the when to the how of antiretroviral initiation
por: Geng, Elvin H., et al.
Publicado: (2017)

A Note on an Improved Self-Healing Group Key Distribution Scheme
por: Guo, Hua, et al.
Publicado: (2015)

Never say “never the twain shall meet”: Combining antiretroviral therapy and RNA vaccine to obtain an adequate humoral immune response in people living with HIV
por: Routy, Jean-Pierre, et al.
Publicado: (2022)

COPD’s early origins in low-and-middle income countries: what are the implications of a false start?
por: Brakema, E. A., et al.
Publicado: (2019)

COVID-19 Pandemic as a Driver for Spreading Virtual Care Globally: The Future Starts Now
por: Denadai, Rafael
Publicado: (2020)

A Higher Number of Covid19 Cases and Fatalities in Israel Phased With the Start of the Mass Vaccination
por: Boretti, Alberto
Publicado: (2021)

When to start antiretroviral therapy: as soon as possible
por: Franco, Ricardo A, et al.
Publicado: (2013)

Antiretroviral Therapy Outcomes among Adolescents and Youth in Rural Zimbabwe
por: Bygrave, Helen, et al.
Publicado: (2012)

Foreword - Kidney disease in disadvantaged populations: an unconquered challenge
por: Prabhakar, Kowdle S., et al.
Publicado: (2015)

Foreword - Kidney disease in disadvantaged populations: An unconquered challenge
por: Norris, Keith C., et al.
Publicado: (2016)

CKD in disadvantaged populations
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2015)

Refueling the Failing Heart: A Case for Sodium-Glucose Cotransporter 2 Inhibition in Cardiac Energy Homeostasis
por: Crawford, Peter A.
Publicado: (2018)

Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention
por: Liebenberg, Lenine J. P., et al.
Publicado: (2017)

Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes consensus conference
por: Levey, Andrew S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ih5833dv3vd4td9b2googlkjgh